No abstract

Use of albendazole medication as an adjuvant to percutaneous treatment of liver hydatid cyst decreases the recurrence rate. Although there is no statistically significant difference between groups 2 and 3 in terms of efficacy and recurrence rate, patients in group 3 had a higher rate of side effect. Therefore, we conclude that albendazole treatment 1 week before and 1 month after PAIR treatment is sufficient to reduce/prevent recurrences.

Treatment of CE types 2 and 3b with the modified catheterization technique was associated with a recurrence rate lower than what is seen with other techniques, and therefore it appears to be a safe, reliable, and efficient alternative.

Combined biliary and duodenal stent placement which can be performed under fluoroscopic guidance without assistance of endoscopy is feasible and an effective method of palliation of malignant biliary and duodenal obstructions. If transoral and endoscopic approaches fail, percutaneous gastrostomy route allows duodenal stenting.

Transhepatic drainage of intraabdominal abscesses under sonographic and fluoroscopic guidance is safe and effective. Abscess content and volume did not affect drainage time, but the presence of a fistula increased the duration of catheter use. The rate of catheter-related complication was highest in the group with 8-French catheters. The rates in the groups with 10- and 12-French catheters did not differ significantly. We suggest the use of 10-French catheters for transhepatic drainage.